Hereditary predisposition to prostate cancer: from genetics to clinical implications
Prostate cancer (PrCa) ranks among the top five cancers for both incidence and mortality
worldwide. A significant proportion of PrCa susceptibility has been attributed to inherited …
worldwide. A significant proportion of PrCa susceptibility has been attributed to inherited …
Implementation of germline testing for prostate cancer: Philadelphia Prostate Cancer Consensus Conference 2019
VN Giri, KE Knudsen, WK Kelly, HH Cheng… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment,
management, and hereditary cancer assessment. Critical needs include optimized …
management, and hereditary cancer assessment. Critical needs include optimized …
Disparities in prostate cancer incidence and mortality rates: Solvable or not?
Prostate cancer (PCa) is recognized as a disease possessing not only great variation in its
geographic and racial distribution but also tremendous variation in its potential to cause …
geographic and racial distribution but also tremendous variation in its potential to cause …
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry
Men of predominantly African Ancestry (AA) have higher prostate cancer (CaP) incidence
and worse survival than men of predominantly European Ancestry (EA). While …
and worse survival than men of predominantly European Ancestry (EA). While …
Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants
Known risk variants explain only a small proportion of breast cancer heritability, particularly
in Asian women. To search for additional genetic susceptibility loci for breast cancer, here …
in Asian women. To search for additional genetic susceptibility loci for breast cancer, here …
An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk
It remains elusive whether some of the associations identified in genome-wide association
studies of prostate cancer (PrCa) may be due to regulatory effects of genetic variants on …
studies of prostate cancer (PrCa) may be due to regulatory effects of genetic variants on …
An epigenome-wide association study of sex-specific chronological ageing
Background Advanced age is associated with cognitive and physical decline and is a major
risk factor for a multitude of disorders. There is also a gap in life expectancy between males …
risk factor for a multitude of disorders. There is also a gap in life expectancy between males …
[HTML][HTML] Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
FC Hamdy, JL Donovan, JA Lane… - Health Technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Prostate cancer is the most common cancer among men in the UK. Prostate-
specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as …
specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as …
Recommandations françaises du Comité de cancérologie de l'AFU–actualisation 2020–2022: cancer de la prostate
F Rozet, P Mongiat-Artus, C Hennequin, JB Beauval… - Progrès en Urologie, 2020 - Elsevier
Objective.-The purpose of the guidelines national committee ccAFU was to propose updated
french guidelines for prostate cancer. Methods.-A Medline search was achieved between …
french guidelines for prostate cancer. Methods.-A Medline search was achieved between …
Using what we already have: uncovering new drug repurposing strategies in existing omics data
JM Pulley, JP Rhoads, RN Jerome… - Annual review of …, 2020 - annualreviews.org
The promise of drug repurposing is to accelerate the translation of knowledge to treatment of
human disease, bypassing common challenges associated with drug development to be …
human disease, bypassing common challenges associated with drug development to be …